Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures.
We treated 11 patients with a persistent (> 3 months), solitary small cysticercus granuloma and seizures with albendazole in a daily dose of 15 mg/kg body weight for 14 days. At repeat CT examinations performed at intervals of 2.5 to 6 weeks after initiation of therapy, the lesions had resolved in two patients and become significantly smaller (less than 50% of their pretreatment size) in two. Albendazole therapy in responders hastened the resolution of the lesions and confirmed the diagnosis.
Rajshekhar
V
V
Department of Neurological Sciences, Christian Medical College Hospital, Vellore, India.
D000293:Adolescent; D000328:Adult; D015766:Albendazole / Q000627:therapeutic use*; D000818:Animals; D001927:Brain Diseases / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D003551:Cysticercosis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D003552:Cysticercus; D005260:Female; D006099:Granuloma / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012640:Seizures / Q000209:etiology*; D014057:Tomography, X-Ray Computed
D015766:Albendazole